3.3 Medications, Allergies, and Sensitivities
Key Takeaways
- Medication review should capture prescription drugs, over-the-counter drugs, supplements, and recent changes.
- Allergy documentation must identify both the agent and the reaction whenever the patient can provide them.
- Latex, local anesthetic, antibiotics, analgesics, dental materials, and topical products all appear in RDA safety scenarios.
- The RDA communicates uncertain or high-risk medication and allergy information to the dentist rather than deciding its clinical significance.
- Anticoagulants, bisphosphonates, and immunosuppressants are high-yield drug classes because they change bleeding, healing, and infection risk.
Medication review that changes dental care
Medication review is broader than "Do you take any pills?" A useful dental record includes prescription medications, over-the-counter (OTC) products, supplements, injections, inhalers, and recent changes. The RDA does not need to recite pharmacology on the exam, but must recognize that medications affect bleeding, healing, alertness, pain control, antibiotic decisions, blood pressure, and emergency risk.
Ask for the medication name, the dose if available, the reason if the patient volunteers it, and whether anything changed. If the patient brings a printed list or a phone photo, follow office procedure to update the record. If the patient cannot name a drug, document that a medication was reported but unidentified, then alert the dentist. A clear "unknown" is safer than a guess.
A few drug classes recur on RDA scenarios because they change clinical risk:
| Drug class | Examples | Why it matters |
|---|---|---|
| Anticoagulants / antiplatelets | warfarin, apixaban, clopidogrel, aspirin | Increased bleeding during and after invasive care |
| Bisphosphonates / antiresorptives | alendronate, zoledronic acid, denosumab | Risk of medication-related osteonecrosis of the jaw (MRONJ) |
| Immunosuppressants / chemotherapy | steroids, transplant drugs, oncology agents | Infection risk and delayed healing |
| Antihypertensives / cardiac drugs | beta blockers, calcium-channel blockers | Affect blood pressure and gingival overgrowth |
| Diabetes medications | insulin, metformin | Hypoglycemia and healing concerns |
Allergies, sensitivities, and latex
Allergy review needs two parts: the agent and the reaction. A chart that only says "allergic" is incomplete. The patient may report hives, swelling, breathing trouble, rash, fainting, nausea, itching, or an unknown childhood reaction. The dentist evaluates clinical significance, but the RDA records the patient-reported reaction accurately and makes sure the team sees it before exposure occurs. Distinguish a true allergy from a side effect: "penicillin makes me vomit" is an intolerance, while "penicillin closes my throat" is a hypersensitivity — record the patient's exact description and let the dentist classify it.
Latex is a frequent exam example because exposure can come from gloves, rubber dam material, prophylaxis angles, orthodontic elastics, or other supplies depending on inventory. The RDA response is not to assume an item is safe; it is to follow the office latex protocol, communicate the allergy, and use dentist-approved alternatives such as nitrile gloves and non-latex dam.
| Item to verify | Examples that may matter | RDA action |
|---|---|---|
| Prescription drugs | anticoagulants, antihypertensives, diabetes drugs | Update the list and flag concerns |
| OTC / herbal products | aspirin, NSAIDs, cold remedies, supplements | Ask specifically; patients overlook these |
| Allergy agents | latex, penicillin, local anesthetic, acrylics, metals | Record the agent and reaction before use |
| Sensitivities | gagging, taste reactions, adhesive irritation | Communicate comfort and safety needs |
| Unknown details | patient cannot name drug or reaction | Document the uncertainty and notify the dentist |
Medication and allergy details also connect to the law-and-ethics side: records must be accurate and protected. Discuss these details only with the patient and the appropriate team members, never in a public area where others can overhear (a confidentiality expectation reinforced by HIPAA and the Dental Practice Act). If a patient says they stopped a drug before the appointment, that is not a green light — record the report and alert the dentist.
Use this chairside list:
- Ask about prescriptions, nonprescription products, supplements, and recent changes.
- Ask what happens when the patient is exposed to a listed allergen.
- Keep the record factual; never guess drug names or classify a reaction as a diagnosis.
- Bring unclear or important information to the dentist before treatment.
- Confirm the operatory setup avoids known allergens when directed.
How medications change what happens at chairside
It helps to connect drug classes to concrete chairside effects, because exam stems test recognition rather than pharmacology. Anticoagulants and antiplatelets mean more bleeding and a longer time to hemostasis, so the dentist needs them flagged before any invasive step; the RDA does not advise the patient to stop them. Antihypertensives such as calcium-channel blockers can cause gingival overgrowth, which the team may notice during the oral exam — another reason the medication list and the clinical picture must travel together.
Diabetes medications raise the chance of a hypoglycemic event, especially if the patient skipped a meal, tying the medication review back to emergency readiness.
Bisphosphonates and other antiresorptives are worth special attention because of medication-related osteonecrosis of the jaw (MRONJ) risk after extractions or other bone-involving care; a patient on long-term alendronate or IV zoledronic acid is exactly the kind of history the dentist must see before planning surgery. Immunosuppressants, steroids, and chemotherapy point toward infection risk and delayed healing. None of these change the RDA's job — document accurately and escalate — but knowing why each matters helps you pick the safest answer when a stem buries a drug name in a routine update.
Allergy traps the exam likes
- "Allergic" with no reaction recorded. Always pursue the agent and the reaction.
- Confusing intolerance with hypersensitivity. Nausea from an antibiotic is a side effect; throat swelling is an allergy. Record the patient's words and let the dentist classify.
- Assuming a short visit avoids exposure. Latex and material allergens are present in routine setups, not just long procedures.
- Discussing details where others can hear. Keep medication and allergy talk private to respect HIPAA and the Dental Practice Act.
Treat the review as exposure prevention rather than form-filling, and the in-scope answer is almost always the one that documents precisely and routes the concern to the dentist.
What two details should the RDA try to capture when a patient reports an allergy?
Why is a bisphosphonate such as alendronate a high-yield medication to document?
A patient reports taking a new blood thinner but does not know the name. What is the best response?
Why can a latex allergy affect the RDA's operatory preparation?